MND: Spasticity can be an MS problem, does it get the attention it deserves? We already posted about baclafen  pumps in wheelchairhealth.net . In a nutshell there were enough successes to talk to your Doctor if you have severe spasticity.

A new study on Intrathecal Baclafen (ITB) for MSers has been published in the MS Journal by a large research team from the US, UK, and Italy [2]. The study point out even though ITB can be effective, it is underutilized by MS doctors. Why?The study claims  their focus is on medications against MS itself (interferons, etc..) and less about helping the symptoms. Also ITB demand specialists to implement  and maintain it. It is also a cost issue. Usually  ITB is a last resort technique. But then again it might be one some patient few options. Escalating oral baclafen has its problems.

Some MS patient have turned to cannabis for spasticity. An English study concludes that it can be useful in some MS cases [3]

So here you are ITB or Cannabis? Might be a clear choice for some , but a comparative study of the efficacies must be done.

Talk to your Doctor

[1]wheelchairhealth ; “Does Baclofen delivered by an implanted programmable pump improve the quality of life in patients with severe spasticity?”

[2] Multiple Sclerosis Journal ; “Intrathecal baclofen in multiple sclerosis: Too little, too late?” ; Mult Scler May 2011 vol. 17 no. 5 623-629

[3] Pubmed; European Journal of Neurology;’Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis”; Eur J Neurol. 2007 Mar;14(3):290-6.

Leave a Reply

Your email address will not be published. Required fields are marked *

Current month ye@r day *

© 2013-2019 Medical News Digest All Rights Reserved